Delivery Order SPE2DB20D3303-SPE2DB26FY2B2
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,417.53 to AmerisourceBergen Drug Corp for the supply of Mercaptopurine 50 mg tablets (250 count) under a firm fixed-price contract. The award was made on August 18, 2025, with an ultimate completion date of August 19, 2025, and is classified as a non-set-aside competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office location. This delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,914.55 firm fixed-price delivery order is for the supply of 4,566,296,059 units of Mercaptopurine 50 mg tablets, with a completion date of November 1, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,927.08, is for the supply of Mercaptopurine 20 mg/mL suspension, a medication used to treat certain types of cancer. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract...
- This delivery order for $3,305.46, awarded by the Defense Logistics Agency to Amerisourcebergen Drug Corp, is for the purchase of 250 tablets of 50 mg mercaptopurine. The order has a firm fixed price and place of performance in Conshohocken, Pennsylvania. No set-aside designation was used for this procurement. The completion date is October 24, 2023, with an award date of October 23, 2023. As the Defense Logistics Agency manages the global supply chain for the Department of Defense, this order...
- The Defense Logistics Agency awarded a delivery order valued at $7,743.92 to AmerisourceBergen Drug Corp for the supply of Imuran 50 mg tablets (100 count) on October 30, 2025, with an ultimate completion date of October 31, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,576.30 in Mycophenolate 500 mg tablets (500-count units) on September 11, 2025, with an ultimate completion date of September 12, 2025. This is a firm fixed-price, non-set-aside contract with performance at the contractor's Conshohocken, Pennsylvania location. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Azathioprine 50 mg tablets in quantities of 100 units, with a ceiling value of $1,109.30. This is a firm fixed price delivery order with an ultimate completion date of August 8, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was made through open competition with no set-aside...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Imuran 50 mg tablets in a quantity of 100 units, with a ceiling value of $1,555.22. This firm fixed-price delivery order represents a non-set-aside competitive award and is scheduled for completion by October 29, 2025. The contract will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $4,451.80 to AmerisourceBergen Drug Corp for the supply of Azathioprine 50 mg tablets (100-count units) on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price, non-set-aside contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Mycophenolic Acid 360 mg tablets (120-count) with a ceiling value of $3,292.46. This firm fixed-price delivery order, which must be completed by September 29, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB26FY2B2Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Mercaptopurine 50 mg tablets in a quantity of 250 units, with a contract ceiling value of $2,011.88. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The order is scheduled for completion by November 5, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement through its DLA contract vehicle, which supports the Defense Health Agency and other military healthcare systems globally. The Mercaptopurine tablets being procured are a chemotherapy medication commonly used in cancer treatment protocols within military healthcare programs. As a prime vendor under the DLA Troop Support Medical program, AmerisourceBergen maintains capability to supply a comprehensive range of pharmaceutical products and medical supplies across multiple therapeutic domains to support military medical operations worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 11/4/25 |